JP2019528279A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019528279A5 JP2019528279A5 JP2019508942A JP2019508942A JP2019528279A5 JP 2019528279 A5 JP2019528279 A5 JP 2019528279A5 JP 2019508942 A JP2019508942 A JP 2019508942A JP 2019508942 A JP2019508942 A JP 2019508942A JP 2019528279 A5 JP2019528279 A5 JP 2019528279A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- halogen
- cycloalkyl
- group
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- CMXLWMLABMJODV-UHFFFAOYSA-N Cc(cc1C(F)(F)F)ccc1Cl Chemical compound Cc(cc1C(F)(F)F)ccc1Cl CMXLWMLABMJODV-UHFFFAOYSA-N 0.000 description 2
- OLECYYBXISHMFS-YGKWUCAESA-N CC(C)/C(/C=C(\C)/C(F)(F)F)=C(/C#C)\F Chemical compound CC(C)/C(/C=C(\C)/C(F)(F)F)=C(/C#C)\F OLECYYBXISHMFS-YGKWUCAESA-N 0.000 description 1
- RWIKZAWYMHSEOC-UHFFFAOYSA-N CC(C)c(cc1)cc(C(F)(F)F)c1F Chemical compound CC(C)c(cc1)cc(C(F)(F)F)c1F RWIKZAWYMHSEOC-UHFFFAOYSA-N 0.000 description 1
- BYPOENRTPJTXAT-UHFFFAOYSA-N CC(C)c1cccc(C(F)(F)F)c1 Chemical compound CC(C)c1cccc(C(F)(F)F)c1 BYPOENRTPJTXAT-UHFFFAOYSA-N 0.000 description 1
- HNKGOFAGRUMTEG-UHFFFAOYSA-N CCc1ccc(C(F)(F)F)c(Cl)c1 Chemical compound CCc1ccc(C(F)(F)F)c(Cl)c1 HNKGOFAGRUMTEG-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662376138P | 2016-08-17 | 2016-08-17 | |
| US62/376,138 | 2016-08-17 | ||
| PCT/US2017/047383 WO2018035346A1 (en) | 2016-08-17 | 2017-08-17 | Kinase inhibitor compounds, compositions, and methods of treating cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019528279A JP2019528279A (ja) | 2019-10-10 |
| JP2019528279A5 true JP2019528279A5 (https=) | 2020-09-17 |
Family
ID=61197083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019508942A Pending JP2019528279A (ja) | 2016-08-17 | 2017-08-17 | キナーゼ阻害物質化合物、組成物、及びがんの治療方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10519113B2 (https=) |
| EP (1) | EP3500257B1 (https=) |
| JP (1) | JP2019528279A (https=) |
| CN (1) | CN110072526A (https=) |
| CA (1) | CA3034332A1 (https=) |
| WO (1) | WO2018035346A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108440404A (zh) * | 2018-05-08 | 2018-08-24 | 西安凯伦生物科技有限公司 | 具有多重激酶抑制作用的抗肿瘤药物及其制备方法和应用 |
| CN111362871B (zh) * | 2018-12-25 | 2022-05-17 | 北京福元医药股份有限公司 | 取代的吡啶-2-甲酰胺类化合物及其用途 |
| KR20220032607A (ko) | 2020-02-27 | 2022-03-15 | 국립대학법인 홋가이도 다이가쿠 | 항암제를 스크리닝하는 방법 및 췌장암 치료를 위한 키나아제 억제제의 조합 의약 |
| CN113402456B (zh) * | 2020-03-16 | 2023-03-03 | 深圳大学 | 一种抗肿瘤药物以及一种化合物或其药学上可接受的盐在抗肿瘤药物中的应用 |
| JP2023525757A (ja) * | 2020-05-08 | 2023-06-19 | ジョージアミューン・インコーポレイテッド | Ａｋｔ３モジュレーター |
| WO2022094477A1 (en) * | 2020-11-02 | 2022-05-05 | Icahn School Of Medicine At Mount Sinai | Methods of treating tumors and cancers having dysregulated wnt signaling pathways |
| KR102710925B1 (ko) * | 2021-06-01 | 2024-09-27 | 부산대학교 산학협력단 | 신규 스퀘어아마이드 유도체 및 이의 용도 |
| WO2025083280A1 (en) * | 2023-10-19 | 2025-04-24 | Universitat De Barcelona | Sorafenib analogs for use in the treatment of cancer |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK286213B6 (sk) * | 1997-12-22 | 2008-05-06 | Bayer Corporation | Substituované heterocyklické močoviny, farmaceutický prípravok ich obsahujúci a ich použitie |
| US7235576B1 (en) * | 2001-01-12 | 2007-06-26 | Bayer Pharmaceuticals Corporation | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| MXPA04007830A (es) * | 2002-02-11 | 2005-07-01 | Bayer Pharmaceuticals Corp | Arilureas como inhibidores de cinasa. |
| CA2494824A1 (en) | 2002-08-08 | 2004-02-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | Fluorinated phenyl-naphthalenyl-urea compounds as inhibitors of cytokines involved in inflammatory processes |
| DE602004030222D1 (de) * | 2003-02-28 | 2011-01-05 | Bayer Healthcare Llc | 2-oxo-1,3,5-perhydrotriazapinderivate, die sich zur behandlung von hyperproliferativen, angiogenen und entzündlichen erkrankungen eignen |
| EP1608639A2 (en) * | 2003-02-28 | 2005-12-28 | Bayer Pharmaceuticals Corporation | Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders |
| WO2004113274A2 (en) | 2003-05-20 | 2004-12-29 | Bayer Pharmaceuticals Corporation | Diaryl ureas with kinase inhibiting activity |
| CA2531485C (en) * | 2003-07-07 | 2013-03-26 | Merck Patent Gmbh | Malonamide derivatives |
| EA010485B1 (ru) * | 2003-07-23 | 2008-10-30 | Байер Фамэсьютиклс Копэрейшн | Производное n,n'-дифенилмочевины, фармацевтическая композиция (варианты) и способ лечения и предупреждения заболеваний и состояний с его использованием (варианты) |
| WO2006026501A1 (en) * | 2004-08-27 | 2006-03-09 | Bayer Pharmaceuticals Corporation | New pharmaceutical compositions for the treatment of cancer |
| US8580798B2 (en) * | 2005-12-21 | 2013-11-12 | Bayer Intellectual Property Gmbh | Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders |
| KR20090071603A (ko) * | 2006-09-19 | 2009-07-01 | 노파르티스 아게 | Ｒａｆ 억제제에 대한 표적 조절, 효능, 진단 및/또는 예후의 바이오마커 |
| CN101260106A (zh) * | 2007-03-06 | 2008-09-10 | 中国药科大学 | Raf激酶抑制剂及其制备方法和用途 |
| US20090012091A1 (en) * | 2007-07-02 | 2009-01-08 | Kinagen, Inc. | Oximide derivatives and their therapeutical application |
| CN101723890B (zh) * | 2008-10-10 | 2011-11-23 | 中国科学院成都生物研究所 | 芳基硫脲及其制备方法和用途 |
| JP2011063516A (ja) * | 2009-09-15 | 2011-03-31 | Daiichi Sankyo Co Ltd | アミド誘導体 |
| WO2011046991A2 (en) * | 2009-10-15 | 2011-04-21 | Gilead Connecticut, Inc. | Certain substituted ureas as modulators of kinase activity |
| US9029401B2 (en) * | 2011-02-14 | 2015-05-12 | The Regents Of The University Of California | Sorafenib derivatives as sEH inhibitors |
| CA2843330C (en) * | 2011-08-03 | 2016-09-20 | National Taiwan University | Substituted phenyl- and heteroaryl-phenyl ether agonists of src homology-2 containing protein tyrosine phosphatase-1 and treatment methods using the same |
| US9090617B1 (en) * | 2011-08-03 | 2015-07-28 | National Taiwan University | Agonists of Src homology-2 containing protein tyrosine phosphatase-1 and treatment methods using the same |
| CN103508961B (zh) * | 2012-06-26 | 2015-07-22 | 中美冠科生物技术（太仓）有限公司 | 抗肿瘤药物 |
| US10449182B2 (en) * | 2012-07-06 | 2019-10-22 | The Regents Of The University Of California | Sorafenib derivatives as p21 inhibitors |
| WO2015051149A1 (en) | 2013-10-04 | 2015-04-09 | The Trustees Of Columbia University In The City Of New York | Sorafenib analogs and uses thereof |
-
2017
- 2017-08-17 EP EP17842133.5A patent/EP3500257B1/en active Active
- 2017-08-17 CN CN201780062024.1A patent/CN110072526A/zh active Pending
- 2017-08-17 US US16/325,218 patent/US10519113B2/en active Active
- 2017-08-17 WO PCT/US2017/047383 patent/WO2018035346A1/en not_active Ceased
- 2017-08-17 JP JP2019508942A patent/JP2019528279A/ja active Pending
- 2017-08-17 CA CA3034332A patent/CA3034332A1/en active Pending
-
2019
- 2019-11-14 US US16/684,159 patent/US11066370B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019528279A5 (https=) | ||
| JP2021169499A5 (https=) | ||
| JP2020169171A5 (https=) | ||
| JP2017504642A5 (https=) | ||
| JP2021514001A5 (https=) | ||
| JP2011509309A5 (https=) | ||
| CN113365998A (zh) | 用于parp抑制剂的吲哚并七元酰肟类似物 | |
| JP2006501295A5 (https=) | ||
| JP2009506119A5 (https=) | ||
| RU2012103487A (ru) | Ингибирующие jak соединения на основе пиразолопиримидина и способы | |
| JP2013209405A5 (https=) | ||
| JP2020522567A5 (https=) | ||
| JP2018135343A5 (https=) | ||
| JP2003520195A5 (https=) | ||
| JP2020502047A5 (https=) | ||
| JP2017538689A5 (https=) | ||
| JP2013533253A5 (https=) | ||
| JP2018514568A5 (https=) | ||
| JPWO2021069705A5 (https=) | ||
| JP2021046404A5 (https=) | ||
| JP2020511547A5 (https=) | ||
| JP2017522304A5 (https=) | ||
| JPWO2019165358A5 (https=) | ||
| JP2019533007A5 (https=) | ||
| JP2010505869A5 (https=) |